Rosetta Licenses Resolver to COR Therapeutics

genomeweb
360dx

Rosetta Licenses Resolver to COR Therapeutics

Nov 26, 2001

NEW YORK, Nov. 26 - Rosetta Biosoftware announced on Monday that it has licensed its Resolver gene-expression data-analysis system to COR Therapeutics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

People in the News: Mary Padbury, Katherine Bach Kalin, Daniel Kolk, More
Low-Frequency Genetic Variations Contribute to Multiple Sclerosis Risk
In Brief This Week: Bruker, OneOme, Becton Dickinson, and More
ASHG: Australian Newborn WES Project Combines Hearing Loss Dx With Optional Secondary Results
Cowen Initiates Coverage of PacBio at Outperform
Epilepsy, Developmental Disorders Linked to De Novo Mutations in Calcium Channel Subunit

The Scan

Sharing, But Kinda Sorta

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

This Week in Science

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

Structural Biologist Leads India's CSIR

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

Upward of One Hundred

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Main menu